Sumitomo Dainippon Pharma and Roivant Sciences to form strategic alliance
TOKYO: Sumitomo Dainippon Pharma has entered into a Memorandum of Understanding for a strategic alliance with Roivant Sciences Ltd. Roivant is expected to receive a total of US$3 billion (approx. ¥320 billion) from Sumitomo Dainippon Pharma, subject to final agreement…